Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety evaluation of ciprofol injection in painless gastrointestinal endoscopy
ChiCTR2100048601Phase 4Not yet recruiting
- Sponsor
- Xinxiang Medical University First Affiliated Hospital
- Start
- Sep 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in gastrointestinal conditions (2 arms), sponsored by Xinxiang Medical University First Affiliated Hospital. Primary endpoint: Vital signs during sedation. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100048601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048601.